Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Current Nutrition Reports
Published in: Current Nutrition Reports 4/2014

01-12-2014 | Diabetes and Obesity (MR Carnethon, Section Editor)

Gene-Diet Interactions in Type 2 Diabetes

Author: Marilyn C. Cornelis

Published in: Current Nutrition Reports | Issue 4/2014

Login to get access

Abstract

Type 2 diabetes (T2D) is thought to arise from an interaction between susceptibility genes and a diabetogenic environment. This review summarizes progress pertaining specifically to gene-diet interactions. Recent efforts have been population-based and have focused on established genetic and dietary risk factors for T2D. TCF7L2 × carbohydrate-quality and IRS1 × macronutrient-composition interactions are promising factors, but most studies of gene-diet interactions are conflicting or need follow-up. T2D genetic risk scores are powerful predictors of developing T2D, but whether they can be combined with dietary risk factors merits further study. Lack of statistical power, imprecise diet measures, and conceptual issues surrounding replication all challenge our efforts to characterize interactions. Collaborations are needed for optimal study designs in both hypothesis-testing and hypothesis-generating contexts. Continued investment in studies of gene-diet interactions may lead to novel mechanistic insights into T2D, opportunities for risk stratification, and ultimately to personalized nutrition to prevent the disease.
Literature
1.
Hogan P, Dall T, Nikolov P. Economic costs of diabetes in the US in 2002. Diabetes Care. 2003;26(3):917–32.PubMed
2.
3.
DeFronzo RA. Pathogenesis of type 2 diabetes: metabolic and molecular implications for identifying diabetes genes. Diabetes Rev. 1997;5(3):177–269.
4.
5.
Poulsen P, Kyvik KO, Vaag A, Beck-Nielsen H. Heritability of type II (non-insulin-dependent) diabetes mellitus and abnormal glucose tolerance–a population-based twin study. Diabetologia. 1999;42(2):139–45.PubMed
6.
Kaprio J, Tuomilehto J, Koskenvuo M, et al. Concordance for type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus in a population-based cohort of twins in Finland. Diabetologia. 1992;35(11):1060–7.PubMed
7.••
Morris AP, Voight BF, Teslovich TM, et al. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet. 2012;44(9):981–90. This article is the latest in a series of successful genome-wide association studies of type 2 diabetes that demonstrate the power of an agnostic system-wide approach to susceptibility loci discovery.PubMedCentralPubMed
8.
Dupuis J, Langenberg C, Prokopenko I, et al. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet. 2010;42(2):105–16.PubMedCentralPubMed
9.
Strawbridge RJ, Dupuis J, Prokopenko I, et al. Genome-wide association identifies nine common variants associated with fasting proinsulin levels and provides new insights into the pathophysiology of type 2 diabetes. Diabetes. 2011;60(10):2624–34.PubMedCentralPubMed
10.
Florez JC. Newly identified loci highlight beta cell dysfunction as a key cause of type 2 diabetes: where are the insulin resistance genes? Diabetologia. 2008;51(7):1100–10.PubMed
11.••
Ley SH, Hamdy O, Mohan V, Hu FB. Prevention and management of type 2 diabetes: dietary components and nutritional strategies. Lancet. 2014;383(9933):1999–2007. This article provides a comprehensive review of dietary factors implicated in the development and management of type 2 diabetes. The work draws on several meta-analyses, large-scale association studies, intervention trials, and other credible literature and resources.PubMed
12.
Koloverou E, Esposito K, Giugliano D, Panagiotakos D. The effect of Mediterranean diet on the development of type 2 diabetes mellitus: a meta-analysis of 10 prospective studies and 136,846 participants. Metabolism. 2014;63(7):903–11.PubMed
13.
Barker DJ. Intrauterine programming of adult disease. Mol Med Today. 1995;1(9):418–23.PubMed
14.
Burdge GC, Lillycrop KA. Nutrition, epigenetics, and developmental plasticity: implications for understanding human disease. Annu Rev Nutr. 2010;30:315–39.PubMed
15.
Patel MS, Srinivasan M. Metabolic programming: causes and consequences. J Biol Chem. 2002;277(3):1629–32.PubMed
16.
Loopstra-Masters RC, Liese AD, Haffner SM, Wagenknecht LE, Hanley AJ. Associations between the intake of caffeinated and decaffeinated coffee and measures of insulin sensitivity and beta cell function. Diabetologia. 2011;54(2):320–8.PubMed
17.
Guerrero-Romero F, Rodriguez-Moran M. Magnesium improves the beta-cell function to compensate variation of insulin sensitivity: double-blind, randomized clinical trial. Eur J Clin Invest. 2011;41(4):405–10.PubMed
18.
Yue F, Zhang X, Zhang H, Jiang X, Gao L, Zhao J. Association of alcohol consumption with the impaired beta-cell function independent of body mass index among Chinese men. Endocr J. 2012;59(5):425–33.PubMed
19.•
Dimas AS, Lagou V, Barker A, et al. Impact of type 2 diabetes susceptibility variants on quantitative glycemic traits reveals mechanistic heterogeneity. Diabetes. 2014;63(6):2158–71. This article examines the relationship between type 2 diabetes risk variants at 37 established susceptibility loci, and indices of proinsulin processing, insulin secretion, and insulin sensitivity. This knowledge may inform the design of future gene-diet interaction studies. PubMed
20.
Wing RR, Goldstein MG, Acton KJ, et al. Behavioral science research in diabetes: lifestyle changes related to obesity, eating behavior, and physical activity. Diabetes Care. 2001;24(1):117–23.PubMed
21.
22.
Neel JV. Diabetes mellitus: a “thrifty” genotype rendered detrimental by “progress”? Am J Hum Genet. 1962;14:353–62.PubMedCentralPubMed
23.
24.
Rothman KJ, Greenland S, editors. Modern epidemiology. Philadelphia: Lippincott Williams and Wilkins; 1998.
25.
Cornelis MC, Hu FB. Gene-environment interactions in the development of type 2 diabetes: recent progress and continuing challenges. Annu Rev Nutr. 2012.
26.
Albert PS, Ratnasinghe D, Tangrea J, Wacholder S. Limitations of the case-only design for identifying gene-environment interactions. Am J Epidemiol. 2001;154(8):687–93.PubMed
27.
Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344(18):1343–50.PubMed
28.
Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393–403.PubMed
29.
Franks PW, Mesa JL, Harding AH, Wareham NJ. Gene-lifestyle interaction on risk of type 2 diabetes. Nutr Metab Cardiovasc Dis. 2007;17(2):104–24.PubMed
30.
Voight BF, Scott LJ, Steinthorsdottir V, et al. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet. 2010;42(7):579–89.PubMedCentralPubMed
31.
Gouda HN, Sagoo GS, Harding AH, Yates J, Sandhu MS, Higgins JP. The association between the peroxisome proliferator-activated receptor-gamma2 (PPARG2) Pro12Ala gene variant and type 2 diabetes mellitus: a HuGE review and meta-analysis. Am J Epidemiol. 2010;171(6):645–55.PubMedCentralPubMed
32.
Tonjes A, Scholz M, Loeffler M, Stumvoll M. Association of Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma with Pre-diabetic phenotypes: meta-analysis of 57 studies on nondiabetic individuals. Diabetes Care. 2006;29(11):2489–97.PubMed
33.
Lazar MA. PPAR gamma, 10 years later. Biochimie. 2005;87(1):9–13.PubMed
34.
Luan J, Browne PO, Harding AH, et al. Evidence for gene-nutrient interaction at the PPARgamma locus. Diabetes. 2001;50(3):686–9.PubMed
35.
Memisoglu A, Hu FB, Hankinson SE, et al. Interaction between a peroxisome proliferator-activated receptor gamma gene polymorphism and dietary fat intake in relation to body mass. Hum Mol Genet. 2003;12(22):2923–9.PubMed
36.
Soriguer F, Morcillo S, Cardona F, et al. Pro12Ala polymorphism of the PPARG2 gene is associated with type 2 diabetes mellitus and peripheral insulin sensitivity in a population with a high intake of oleic acid. J Nutr. 2006;136(9):2325–30.PubMed
37.
Ylonen SK, Salminen I, Lyssenko V, et al. The Pro12Ala polymorphism of the PPAR-gamma2 gene affects associations of fish intake and marine n-3 fatty acids with glucose metabolism. Eur J Clin Nutr. 2008;62(12):1432–9.PubMed
38.
Robitaille J, Despres JP, Perusse L, Vohl MC. The PPAR-gamma P12A polymorphism modulates the relationship between dietary fat intake and components of the metabolic syndrome: results from the Quebec Family Study. Clin Genet. 2003;63(2):109–16.PubMed
39.
Lamri A, Abi Khalil C, Jaziri R, et al. Dietary fat intake and polymorphisms at the PPARG locus modulate BMI and type 2 diabetes risk in the D.E.S.I.R. prospective study. Int J Obes (Lond). 2011.
40.
Lamri A, Abi Khalil C, Jaziri R, et al. Dietary fat intake and polymorphisms at the PPARG locus modulate BMI and type 2 diabetes risk in the D.E.S.I.R. prospective study. Int J Obes (Lond). 2012;36(2):218–24.
41.
Nelson TL, Fingerlin TE, Moss LK, Barmada MM, Ferrell RE, Norris JM. Association of the peroxisome proliferator-activated receptor gamma gene with type 2 diabetes mellitus varies by physical activity among non-Hispanic whites from Colorado. Metabolism. 2007;56(3):388–93.PubMed
42.
Patel CJ, Chen R, Kodama K, Ioannidis JP, Butte AJ. Systematic identification of interaction effects between genome- and environment-wide associations in type 2 diabetes mellitus. Hum Genet. 2013;132(5):495–508.PubMedCentralPubMed
43.
Pisabarro RE, Sanguinetti C, Stoll M, Prendez D. High incidence of type 2 diabetes in peroxisome proliferator-activated receptor gamma2 Pro12Ala carriers exposed to a high chronic intake of trans fatty acids and saturated fatty acids. Diabetes Care. 2004;27(9):2251–2.PubMed
44.
Lindi VI, Uusitupa MI, Lindstrom J, et al. Association of the Pro12Ala polymorphism in the PPAR-gamma2 gene with 3-year incidence of type 2 diabetes and body weight change in the Finnish Diabetes Prevention Study. Diabetes. 2002;51(8):2581–6.PubMed
45.
Florez JC, Jablonski KA, Sun MW, et al. Effects of the type 2 diabetes-associated PPARG P12A polymorphism on progression to diabetes and response to troglitazone. J Clin Endocrinol Metab. 2007;92(4):1502–9.PubMedCentralPubMed
46.
Jablonski KA, McAteer JB, de Bakker PI, et al. Common variants in 40 genes assessed for diabetes incidence and response to metformin and lifestyle intervention in the diabetes prevention program. Diabetes. 2010;59(10):2672–81.PubMedCentralPubMed
47.
Cornelis MC, Qi L, Kraft P, Hu FB. TCF7L2, dietary carbohydrate, and risk of type 2 diabetes in US women. Am J Clin Nutr. 2009;89(4):1256–62.PubMedCentralPubMed
48.
Fisher E, Boeing H, Fritsche A, Doering F, Joost HG, Schulze MB. Whole-grain consumption and transcription factor-7-like 2 ( TCF7L2) rs7903146: gene-diet interaction in modulating type 2 diabetes risk. Br J Nutr. 2009;101(4):478–81.PubMed
49.
Wirstrom T, Hilding A, Gu HF, Ostenson CG, Bjorklund A. Consumption of whole grain reduces risk of deteriorating glucose tolerance, including progression to prediabetes. Am J Clin Nutr. 2013;97(1):179–87.PubMed
50.
Hindy G, Sonestedt E, Ericson U, et al. Role of TCF7L2 risk variant and dietary fibre intake on incident type 2 diabetes. Diabetologia. 2012;55(10):2646–54.PubMedCentralPubMed
51.
Villegas R, Goodloe RJ, McClellan Jr BE, Boston J, Crawford DC. Gene-carbohydrate and gene-fiber interactions and type 2 diabetes in diverse populations from the National Health and Nutrition Examination Surveys (NHANES) as part of the Epidemiologic Architecture for Genes Linked to Environment (EAGLE) study. BMC Genet. 2014;15:69.PubMedCentralPubMed
52.
Nettleton JA, McKeown NM, Kanoni S, et al. Interactions of dietary whole-grain intake with fasting glucose- and insulin-related genetic loci in individuals of European descent: a meta-analysis of 14 cohort studies. Diabetes Care. 2010;33(12):2684–91.PubMedCentralPubMed
53.
Wang J, Li L, Zhang J, et al. Association of rs7903146 (IVS3C/T) and rs290487 (IVS3C/T) polymorphisms in TCF7L2 with type 2 diabetes in 9,619 Han Chinese population. PLoS ONE. 2013;8(3):e59053.PubMedCentralPubMed
54.
Pulizzi N, Lyssenko V, Jonsson A, et al. Interaction between prenatal growth and high-risk genotypes in the development of type 2 diabetes. Diabetologia. 2009;52(5):825–9.PubMed
55.
van Hoek M, Langendonk JG, de Rooij SR, Sijbrands EJ, Roseboom TJ. Genetic variant in the IGF2BP2 gene may interact with fetal malnutrition to affect glucose metabolism. Diabetes. 2009;58(6):1440–4.PubMedCentralPubMed
56.
Florez JC, Jablonski KA, Bayley N, et al. TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program. N Engl J Med. 2006;355(3):241–50.PubMedCentralPubMed
57.
Rutter GA. Think zinc: new roles for zinc in the control of insulin secretion. Islets. 2010;2(1):49–50.PubMed
58.
Myers SA, Nield A, Myers M. Zinc transporters, mechanisms of action and therapeutic utility: implications for type 2 diabetes mellitus. J Nutr Metab. 2012;2012:173712.PubMedCentralPubMed
59.
Beletate V, El Dib RP, Atallah AN. Zinc supplementation for the prevention of type 2 diabetes mellitus. Cochrane Database Syst Rev. 2007;1, CD005525.PubMed
60.
Shan Z, Bao W, Zhang Y, et al. Interactions between zinc transporter-8 gene (SLC30A8) and plasma zinc concentrations for impaired glucose regulation and type 2 diabetes. Diabetes. 2014;63(5):1796–803.PubMed
61.
Kanoni S, Nettleton JA, Hivert MF, et al. Total zinc intake may modify the glucose-raising effect of a zinc transporter (SLC30A8) variant: a 14-cohort meta-analysis. Diabetes. 2011;60(9):2407–16.PubMedCentralPubMed
62.
Billings LK, Jablonski KA, Ackerman RJ, et al. The influence of rare genetic variation in SLC30A8 on diabetes incidence and beta-cell function. J Clin Endocrinol Metab. 2014;99(5):E926–30.PubMed
63.
Zeggini E, Weedon MN, Lindgren CM, et al. Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science. 2007;316(5829):1336–41.PubMedCentralPubMed
64.
Marzo N, Mora C, Fabregat ME, et al. Pancreatic islets from cyclin-dependent kinase 4/R24C (Cdk4) knockin mice have significantly increased beta cell mass and are physiologically functional, indicating that Cdk4 is a potential target for pancreatic beta cell mass regeneration in Type 1 diabetes. Diabetologia. 2004;47(4):686–94.
65.
Mettus RV, Rane SG. Characterization of the abnormal pancreatic development, reduced growth and infertility in Cdk4 mutant mice. Oncogene. 2003;22(52):8413–21.PubMed
66.
Moore AF, Jablonski KA, McAteer JB, et al. Extension of type 2 diabetes genome-wide association scan results in the diabetes prevention program. Diabetes. 2008;57(9):2503–10.PubMedCentralPubMed
67.
Almind K, Inoue G, Pedersen O, Kahn CR. A common amino acid polymorphism in insulin receptor substrate-1 causes impaired insulin signaling. Evidence from transfection studies. J Clin Invest. 1996;97(11):2569–75.PubMedCentralPubMed
68.
Laukkanen O, Pihlajamaki J, Lindstrom J, et al. Common polymorphisms in the genes regulating the early insulin signalling pathway: effects on weight change and the conversion from impaired glucose tolerance to Type 2 diabetes. The Finnish Diabetes Prevention Study. Diabetologia. 2004;47(5):871–7.PubMed
69.
Marin C, Perez-Martinez P, Delgado-Lista J, et al. The insulin sensitivity response is determined by the interaction between the G972R polymorphism of the insulin receptor substrate 1 gene and dietary fat. Mol Nutr Food Res. 2011;55(2):328–35.PubMed
70.
Kilpelainen TO, Zillikens MC, Stancakova A, et al. Genetic variation near IRS1 associates with reduced adiposity and an impaired metabolic profile. Nat Genet. 2011;43(8):753–60.PubMedCentralPubMed
71.
Rung J, Cauchi S, Albrechtsen A, et al. Genetic variant near IRS1 is associated with type 2 diabetes, insulin resistance and hyperinsulinemia. Nat Genet. 2009;41(10):1110–5.PubMed
72.
Ericson U, Rukh G, Stojkovic I, et al. Sex-specific interactions between the IRS1 polymorphism and intakes of carbohydrates and fat on incident type 2 diabetes. Am J Clin Nutr. 2013;97(1):208–16.PubMed
73.
Zheng JS, Arnett DK, Parnell LD, et al. Modulation by dietary fat and carbohydrate of IRS1 association with type 2 diabetes traits in two populations of different ancestries. Diabetes Care. 2013;36(9):2621–7.PubMedCentralPubMed
74.
Qi Q, Xu M, Wu H, et al. IRS1 genotype modulates metabolic syndrome reversion in response to 2-year weight-loss diet intervention: the POUNDS LOST trial. Diabetes Care. 2013;36(11):3442–7.PubMed
75.
Qi Q, Bray GA, Smith SR, Hu FB, Sacks FM, Qi L. Insulin receptor substrate 1 gene variation modifies insulin resistance response to weight-loss diets in a 2-year randomized trial: the Preventing Overweight Using Novel Dietary Strategies (POUNDS LOST) trial. Circulation. 2011;124(5):563–71.PubMedCentralPubMed
76.
Speliotes EK, Willer CJ, Berndt SI, et al. Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet. 2010;42(11):937–48.PubMedCentralPubMed
77.
Saxena R, Hivert MF, Langenberg C, et al. Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge. Nat Genet. 2010;42(2):142–8.PubMedCentralPubMed
78.
Meyre D. Is FTO, a type 2 diabetes susceptibility gene? Diabetologia. 2012;55(4):873–6.PubMed
79.
Lyssenko V, Eliasson L, Kotova O, et al. Pleiotropic effects of GIP on islet function involve osteopontin. Diabetes. 2011;60(9):2424–33.PubMedCentralPubMed
80.
Ortega-Azorin C, Sorli JV, Asensio EM, et al. Associations of the FTO rs9939609 and the MC4R rs17782313 polymorphisms with type 2 diabetes are modulated by diet, being higher when adherence to the Mediterranean diet pattern is low. Cardiovasc Diabetol. 2012;11:137.PubMedCentralPubMed
81.
Sonestedt E, Lyssenko V, Ericson U, et al. Genetic variation in the glucose-dependent insulinotropic polypeptide receptor modifies the association between carbohydrate and fat intake and risk of type 2 diabetes in the Malmo Diet and Cancer cohort. J Clin Endocrinol Metab. 2012;97(5):E810–8.PubMed
82.
Qi Q, Bray GA, Hu FB, Sacks FM, Qi L. Weight-loss diets modify glucose-dependent insulinotropic polypeptide receptor rs2287019 genotype effects on changes in body weight, fasting glucose, and insulin resistance: the Preventing Overweight Using Novel Dietary Strategies trial. Am J Clin Nutr. 2012;95(2):506–13.PubMedCentralPubMed
83.
Lappalainen TJ, Tolppanen AM, Kolehmainen M, et al. The common variant in the FTO gene did not modify the effect of lifestyle changes on body weight: the Finnish Diabetes Prevention Study. Obesity (Silver Spring). 2009;17(4):832–6.
84.
Cornelis MC, Qi L, Zhang C, et al. Joint effects of common genetic variants on the risk for type 2 diabetes in U.S. men and women of European ancestry. Ann Intern Med. 2009;150(8):541–50.PubMedCentralPubMed
85.
Qi L, Cornelis MC, Zhang C, van Dam RM, Hu FB. Genetic predisposition, Western dietary pattern, and the risk of type 2 diabetes in men. Am J Clin Nutr. 2009;89(5):1453–8.PubMedCentralPubMed
86.••
Langenberg C, Sharp SJ, Franks PW, et al. Gene-lifestyle interaction and type 2 diabetes: the EPIC interact case-cohort study. PLoS Med. 2014;11(5):e1001647. This is a recent study from a series of large-scale gene-environment interaction studies coordinated by consortia. See the Table 1 entry for this study. No interactions were observed between the T2D GRS and sex, diabetes family history, physical activity, or dietary habits assessed by a Mediterranean diet score. The relative effect of the T2D GRS was reportedly greater in younger and leaner participants. However, the investigators emphasize that on an absolute risk scale this subgroup would not be a logical target for preventive interventions.PubMedCentralPubMed
87.
Li Y, Qi Q, Workalemahu T, Hu FB, Qi L. Birth weight, genetic susceptibility, and adulthood risk of type 2 diabetes. Diabetes Care. 2012;35(12):2479–84.PubMedCentralPubMed
88.
Bookman EB, McAllister K, Gillanders E, et al. Gene-environment interplay in common complex diseases: forging an integrative model-recommendations from an NIH workshop. Genet Epidemiol. 2011.
89.
Hunter DJ. Gene-environment interactions in human diseases. Nat Rev Genet. 2005;6(4):287–98.PubMed
90.
Kraft P, Hunter D. Integrating epidemiology and genetic association: the challenge of gene-environment interaction. Philos Trans R Soc Lond B Biol Sci. 2005;360(1460):1609–16.PubMedCentralPubMed
91.
Moffitt TE, Caspi A, Rutter M. Strategy for investigating interactions between measured genes and measured environments. Arch Gen Psychiatry. 2005;62(5):473–81.PubMed
92.
Smith PG, Day NE. The design of case-control studies: the influence of confounding and interaction effects. Int J Epidemiol. 1984;13(3):356–65.PubMed
93.
Palla L, Higgins JP, Wareham NJ, Sharp SJ. Challenges in the use of literature-based meta-analysis to examine gene-environment interactions. Am J Epidemiol. 2010;171(11):1225–32.PubMed
94.
Moore SC, Gunter MJ, Daniel CR, et al. Common genetic variants and central adiposity among Asian-Indians. Obesity (Silver Spring). 2011.
95.
Kilpelainen TO, Qi L, Brage S, et al. Physical activity attenuates the influence of FTO variants on obesity risk: a meta-analysis of 218,166 adults and 19,268 children. PLoS Med. 2011;8(11):e1001116.PubMedCentralPubMed
96.
Scott RA, Chu AY, Grarup N, et al. No interactions between previously associated 2-hour glucose gene variants and physical activity or BMI on 2-hour glucose levels. Diabetes. 2012;61(5):1291–6.PubMedCentralPubMed
97.
Wild CP. The exposome: from concept to utility. Int J Epidemiol. 2012;41(1):24–32.PubMed
98.
Martin Sanchez F, Gray K, Bellazzi R, Lopez-Campos G. Exposome informatics: considerations for the design of future biomedical research information systems. J Am Med Inform Assoc. 2014;21(3):386–90.PubMed
99.
Zheng JS, Parnell LD, Smith CE, et al. Circulating 25-hydroxyvitamin D, IRS1 variant rs2943641, and insulin resistance: replication of a gene-nutrient interaction in 4 populations of different ancestries. Clin Chem. 2014;60(1):186–96.PubMedCentralPubMed
100.
Willett WC. Nutritional epidemiology. New York: Oxford University Press; 1998.
101.
Stover PJ, Harlan WR, Hammond JA, Hendershot T, Hamilton CM. PhenX: a toolkit for interdisciplinary genetics research. Curr Opin Lipidol. 2010;21(2):136–40.PubMed
102.•
Anuradha CV. Phytochemicals targeting genes relevant for type 2 diabetes. Can J Physiol Pharmacol. 2013;91(6):397–411. This article provides a comprehensive review of the literature pertaining to phytochemicals/extracts that may target diabetogenic genes. A prospective on nutritional therapy of T2D is also provided.PubMed
103.••
Shin SY, Fauman EB, Petersen AK, et al. An atlas of genetic influences on human blood metabolites. Nat Genet. 2014;46(6):543–50. This study provides the most comprehensive exploration of genetic loci influencing human metabolism thus far. The investigators report genome-wide significant associations at 145 metabolic loci and their biochemical connectivity with more than 400 metabolites in human blood. Some of these loci overlap with those associated with T2D (see Table 2 in the current paper). Links between these loci and metabolites may, thus, provide mechanistic insight into the role of these loci (or metabolites) in T2D development. PubMed
104.
105.••
Thomas DC, Lewinger JP, Murcray CE, Gauderman WJ. Invited commentary: GE-Whiz! Ratcheting gene-environment studies up to the whole genome and the whole exposome. Am J Epidemiol. 2012;175(3):203–7. discussion 208–209. This Invited Commentary discusses recent approaches to genome-wide environment interaction studies with special reference to findings from two recent studies in the same issue of the journal (Cornelis et al. 2012 and Mukherjee et al. 2012).PubMedCentralPubMed
106.
Franks PW. Gene x environment interactions in type 2 diabetes. Curr Diab Rep. 2011;11(6):552–61.PubMed
107.
Khoury MJ, Wacholder S. Invited commentary: from genome-wide association studies to gene-environment-wide interaction studies–challenges and opportunities. Am J Epidemiol. 2009;169(2):227–30. discussion 234-225.PubMedCentralPubMed
108.•
Mukherjee B, Ahn J, Gruber SB, Chatterjee N. Testing gene-environment interaction in large-scale case-control association studies: possible choices and comparisons. Am J Epidemiol. 2012;175(3):177–90. This article presents a comparative simulation study of power and type I error properties of several statistical methods for genome-wide environment interaction testing. Importance of the findings are reviewed by Thomas et al. 2012 in the same issue of the Journal. PubMedCentralPubMed
109.•
Cornelis MC, Tchetgen Tchetgen EJ, Liang L, et al. Gene-environment interactions in genome-wide association studies: a comparative study of tests applied to empirical studies of type 2 diabetes. Am J Epidemiol. 2012;175(3):191–202. This study compares the performance of several statistical methods for testing gene-environment interactions in the context of GWAS using two case-control GWAS of type 2 diabetes. The importance of the findings are reviewed by Thomas et al. 2012 in the same issue of the Journal.PubMedCentralPubMed
110.
Ritchie MD, Motsinger AA. Multifactor dimensionality reduction for detecting gene-gene and gene-environment interactions in pharmacogenomics studies. Pharmacogenomics. 2005;6(8):823–34.PubMed
111.
Hung RJ, Brennan P, Malaveille C, et al. Using hierarchical modeling in genetic association studies with multiple markers: application to a case-control study of bladder cancer. Cancer Epidemiol Biomarkers Prev. 2004;13(6):1013–21.PubMed
112.
Patel CJ, Chen R, Butte AJ. Data-driven integration of epidemiological and toxicological data to select candidate interacting genes and environmental factors in association with disease. Bioinformatics. 2012;28(12):i121–6.PubMedCentralPubMed
113.
Kraft P, Yen YC, Stram DO, Morrison J, Gauderman WJ. Exploiting gene-environment interaction to detect genetic associations. Hum Hered. 2007;63(2):111–9.PubMed
114.
Zaitlen N, Lindstrom S, Pasaniuc B, et al. Informed conditioning on clinical covariates increases power in case-control association studies. PLoS Genet. 2012;8(11):e1003032.PubMedCentralPubMed
115.
Grarup N, Andersen G. Gene-environment interactions in the pathogenesis of type 2 diabetes and metabolism. Curr Opin Clin Nutr Metab Care. 2007;10(4):420–6.PubMed
116.
Ordovas JM, Tai ES. Why study gene-environment interactions? Curr Opin Lipidol. 2008;19(2):158–67.PubMed
117.
Nemoto M, Sasaki T, Deeb SS, Fujimoto WY, Tajima N. Differential effect of PPARgamma2 variants in the development of type 2 diabetes between native Japanese and Japanese Americans. Diabetes Res Clin Pract. 2002;57(2):131–7.PubMed
118.
Fisher E, Schreiber S, Joost HG, Boeing H, Doring F. A two-step association study identifies CAV2 rs2270188 single nucleotide polymorphism interaction with fat intake in type 2 diabetes risk. J Nutr. 2011;141(2):177–81.PubMed
119.
Florez JC, Jablonski KA, McAteer J, et al. Testing of diabetes-associated WFS1 polymorphisms in the Diabetes Prevention Program. Diabetologia. 2008;51(3):451–7.PubMedCentralPubMed
120.
Pollin TI, Jablonski KA, McAteer JB, et al. Triglyceride response to an intensive lifestyle intervention is enhanced in carriers of the GCKR Pro446Leu polymorphism. J Clin Endocrinol Metab. 2011;96(7):E1142–7.PubMedCentralPubMed
121.
Su Y, Simmen FA, Xiao R, Simmen RC. Expression profiling of rat mammary epithelial cells reveals candidate signaling pathways in dietary protection from mammary tumors. Physiol Genomics. 2007;30(1):8–16.PubMed
122.
Richard D, Oszust F, Guillaume C, et al. Infusion of docosahexaenoic acid protects against myocardial infarction. Prostaglandins Leukot Essent Fat Acids. 2014;90(4):139–43.
123.
Hall E, Volkov P, Dayeh T, et al. Effects of palmitate on genome-wide mRNA expression and DNA methylation patterns in human pancreatic islets. BMC Med. 2014;12:103.PubMedCentralPubMed
124.
Tsiftsoglou AS, Vizirianakis IS, Strouboulis J. Erythropoiesis: model systems, molecular regulators, and developmental programs. IUBMB Life. 2009;61(8):800–30.PubMed
125.
Park JJ, Berggren JR, Hulver MW, Houmard JA, Hoffman EP. GRB14, GPD1, and GDF8 as potential network collaborators in weight loss-induced improvements in insulin action in human skeletal muscle. Physiol Genomics. 2006;27(2):114–21.PubMed
126.
Lu J, Zeng Y, Hou W, et al. The soybean peptide aglycin regulates glucose homeostasis in type 2 diabetic mice via IR/IRS1 pathway. J Nutr Biochem. 2012;23(11):1449–57.PubMed
127.
Montagut G, Blade C, Blay M, et al. Effects of a grapeseed procyanidin extract (GSPE) on insulin resistance. J Nutr Biochem. 2010;21(10):961–7.PubMed
128.
Balage M, Dupont J, Mothe-Satney I, Tesseraud S, Mosoni L, Dardevet D. Leucine supplementation in rats induced a delay in muscle IR/PI3K signaling pathway associated with overall impaired glucose tolerance. J Nutr Biochem. 2011;22(3):219–26.PubMed
129.
Qin B, Polansky MM, Anderson RA. Cinnamon extract regulates plasma levels of adipose-derived factors and expression of multiple genes related to carbohydrate metabolism and lipogenesis in adipose tissue of fructose-fed rats. Horm Metab Res. 2010;42(3):187–93.PubMed
130.
Banas SM, Rouch C, Kassis N, Markaki EM, Gerozissis K. A dietary fat excess alters metabolic and neuroendocrine responses before the onset of metabolic diseases. Cell Mol Neurobiol. 2009;29(2):157–68.PubMed
131.
Alkharfy KM, Al-Daghri NM, Yakout SM, Hussain T, Mohammed AK, Krishnaswamy S. Influence of vitamin D treatment on transcriptional regulation of insulin-sensitive genes. Metab Syndr Relat Disord. 2013;11(4):283–8.PubMed
132.
Babacanoglu C, Yildirim N, Sadi G, Pektas MB, Akar F. Resveratrol prevents high-fructose corn syrup-induced vascular insulin resistance and dysfunction in rats. Food Chem Toxicol. 2013;60:160–7.PubMed
133.
Toyoshima Y, Ohne Y, Takahashi SI, Noguchi T, Kato H. Dietary protein deprivation decreases the serine phosphorylation of insulin receptor substrate-1 in rat skeletal muscle. J Mol Endocrinol. 2004;32(2):519–31.PubMed
134.
Murata M, Kaji H, Iida K, Okimura Y, Chihara K. Dual action of eicosapentaenoic acid in hepatoma cells: up-regulation of metabolic action of insulin and inhibition of cell proliferation. J Biol Chem. 2001;276(33):31422–8.PubMed
135.
Moon JH, Lee JY, Kang SB, et al. Dietary monounsaturated fatty acids but not saturated fatty acids preserve the insulin signaling pathway via IRS-1/PI3K in rat skeletal muscle. Lipids. 2010;45(12):1109–16.PubMed
136.
Lennon R, Pons D, Sabin MA, et al. Saturated fatty acids induce insulin resistance in human podocytes: implications for diabetic nephropathy. Nephrol Dial Transplant. 2009;24(11):3288–96.PubMed
137.
Solinas G, Naugler W, Galimi F, Lee MS, Karin M. Saturated fatty acids inhibit induction of insulin gene transcription by JNK-mediated phosphorylation of insulin-receptor substrates. Proc Natl Acad Sci U S A. 2006;103(44):16454–9.PubMedCentralPubMed
138.
Ho MM, Yoganathan P, Chu KY, Karunakaran S, Johnson JD, Clee SM. Diabetes genes identified by genome-wide association studies are regulated in mice by nutritional factors in metabolically relevant tissues and by glucose concentrations in islets. BMC Genet. 2013;14:10.PubMedCentralPubMed
139.
Yoshimura M, Pearson S, Kadota Y, Gonzalez CE. Identification of ethanol responsive domains of adenylyl cyclase. Alcohol Clin Exp Res. 2006;30(11):1824–32.PubMed
140.
Rabbani M, Nelson EJ, Hoffman PL, Tabakoff B. Role of protein kinase C in ethanol-induced activation of adenylyl cyclase. Alcohol Clin Exp Res. 1999;23(1):77–86.PubMed
141.
Socha P, Grote V, Gruszfeld D, et al. Milk protein intake, the metabolic-endocrine response, and growth in infancy: data from a randomized clinical trial. Am J Clin Nutr. 2011;94(6 Suppl):1776S–84S.PubMed
142.
Dreja T, Jovanovic Z, Rasche A, et al. Diet-induced gene expression of isolated pancreatic islets from a polygenic mouse model of the metabolic syndrome. Diabetologia. 2010;53(2):309–20.PubMedCentralPubMed
143.
Pendse J, Ramachandran PV, Na J, et al. A Drosophila functional evaluation of candidates from human genome-wide association studies of type 2 diabetes and related metabolic traits identifies tissue-specific roles for dHHEX. BMC Genomics. 2013;14:136.PubMedCentralPubMed
144.
Nojima K, Sugimoto K, Ueda H, Babaya N, Ikegami H, Rakugi H. Analysis of hepatic gene expression profile in a spontaneous mouse model of type 2 diabetes under a high sucrose diet. Endocr J. 2013;60(3):261–74.PubMed
145.
Lu P, Bar-Yoseph F, Levi L, et al. High beta-palmitate fat controls the intestinal inflammatory response and limits intestinal damage in mucin Muc2 deficient mice. PLoS ONE. 2013;8(6):e65878.PubMedCentralPubMed
146.
Kadegowda AK, Khan MJ, Piperova LS, et al. Trans-10, cis 12-conjugated linoleic acid-induced milk fat depression is associated with inhibition of PPARgamma signaling and inflammation in murine mammary tissue. J Lipids. 2013;2013:890343.PubMedCentralPubMed
147.
Ables GP, Perrone CE, Orentreich D, Orentreich N. Methionine-restricted C57BL/6J mice are resistant to diet-induced obesity and insulin resistance but have low bone density. PLoS ONE. 2012;7(12):e51357.
148.
Jung CH, Ahn J, Jeon TI, Kim TW, Ha TY. Syzygium aromaticum ethanol extract reduces high-fat diet-induced obesity in mice through downregulation of adipogenic and lipogenic gene expression. Exp Ther Med. 2012;4(3):409–14.PubMedCentralPubMed
149.
Jung CH, Cho I, Ahn J, Jeon TI, Ha TY. Quercetin reduces high-fat diet-induced fat accumulation in the liver by regulating lipid metabolism genes. Phytother Res. 2013;27(1):139–43.PubMed
150.
Matsuo T, Nakata Y, Katayama Y, et al. PPARG genotype accounts for part of individual variation in body weight reduction in response to calorie restriction. Obesity (Silver Spring). 2009;17(10):1924–31.
151.
Bitto A, Altavilla D, Bonaiuto A, et al. Effects of aglycone genistein in a rat experimental model of postmenopausal metabolic syndrome. J Endocrinol. 2009;200(3):367–76.PubMed
152.
AlSaleh A, Sanders TA, O’Dell SD. Effect of interaction between PPARG, PPARA and ADIPOQ gene variants and dietary fatty acids on plasma lipid profile and adiponectin concentration in a large intervention study. Proc Nutr Soc. 2012;71(1):141–53.PubMed
153.
Ruiz-Narvaez EA, Kraft P, Campos H. Ala12 variant of the peroxisome proliferator-activated receptor-gamma gene (PPARG) is associated with higher polyunsaturated fat in adipose tissue and attenuates the protective effect of polyunsaturated fat intake on the risk of myocardial infarction. Am J Clin Nutr. 2007;86(4):1238–42.PubMed
154.
Jiang DF, Li WT, Yang HL, Zhang ZZ, Chen D, Sun C. Long-term effects of evodiamine on expressions of lipogenesis and lipolysis genes in mouse adipose and liver tissues. Genet Mol Res. 2014;13(1):1038–46.PubMed
155.
Hiller B, Angulo J, Olivera M, Nuernberg G, Nuernberg K. How selected tissues of lactating holstein cows respond to dietary polyunsaturated fatty acid supplementation. Lipids. 2013;48(4):357–67.PubMed
156.
Takeda E, Arai H, Muto K, et al. Gene expression in low glycemic index diet - impact on metabolic control. Forum Nutr. 2007;60:127–39.PubMed
157.
Yin L, Unger EL, Jellen LC, et al. Systems genetic analysis of multivariate response to iron deficiency in mice. Am J Physiol. 2012;302(11):R1282–96.
158.
Gong M, Garige M, Hirsch K, Lakshman MR. Liver Galbeta1,4GlcNAc alpha2,6-sialyltransferase is down-regulated in human alcoholics: possible cause for the appearance of asialoconjugates. Metabolism. 2007;56(9):1241–7.PubMedCentralPubMed
159.
Garige M, Gong M, Rao MN, Zhang Y, Lakshman MR. Mechanism of action of ethanol in the down-regulation of Gal(beta)1, 4GlcNAc alpha2,6-sialyltransferase messenger RNA in human liver cell lines. Metabolism. 2005;54(6):729–34.PubMed
160.
Sakurai T, Kitadate K, Nishioka H, et al. Oligomerised lychee fruit-derived polyphenol attenuates cognitive impairment in senescence-accelerated mice and endoplasmic reticulum stress in neuronal cells. Br J Nutr. 2013;110(9):1549–58.PubMed
161.
Han H, Hu J, Lau MY, Feng M, Petrovic LM, Ji C. Altered methylation and expression of ER-associated degradation factors in long-term alcohol and constitutive ER stress-induced murine hepatic tumors. Front Genet. 2013;4:224.PubMedCentralPubMed
162.
Okamura T, Yanobu-Takanashi R, Takeuchi F, et al. Deletion of CDKAL1 affects high-fat diet-induced fat accumulation and glucose-stimulated insulin secretion in mice, indicating relevance to diabetes. PLoS ONE. 2012;7(11):e49055.PubMedCentralPubMed
163.
Lin W, Burks CA, Hansen DR, Kinnamon SC, Gilbertson TA. Taste receptor cells express pH-sensitive leak K+ channels. J Neurophysiol. 2004;92(5):2909–19.PubMed
164.
Muller YL, Piaggi P, Hoffman D, et al. Common genetic variation in the glucokinase gene (GCK) is associated with type 2 diabetes and rates of carbohydrate oxidation and energy expenditure. Diabetologia. 2014;57(7):1382–90.PubMedCentralPubMed
165.
Klupa T, Solecka I, Nowak N, et al. The influence of dietary carbohydrate content on glycaemia in patients with glucokinase maturity-onset diabetes of the young. J Int Med Res. 2011;39(6):2296–301.PubMed
166.
Bouchard-Mercier A, Rudkowska I, Lemieux S, Couture P, Vohl MC. An interaction effect between glucokinase gene variation and carbohydrate intakes modulates the plasma triglyceride response to a fish oil supplementation. Genes Nutr. 2014;9(3):395.PubMedCentralPubMed
167.
Zhang Y, Li R, Li Y, Chen W, Zhao S, Chen G. Vitamin A status affects obesity development and hepatic expression of key genes for fuel metabolism in Zucker fatty rats. Biochem Cell Biol. 2012;90(4):548–57.PubMed
168.
Sakamoto E, Seino Y, Fukami A, et al. Ingestion of a moderate high-sucrose diet results in glucose intolerance with reduced liver glucokinase activity and impaired glucagon-like peptide-1 secretion. J Diabetes Investig. 2012;3(5):432–40.PubMedCentralPubMed
169.
Kim JY, Song EH, Lee HJ, et al. Chronic ethanol consumption-induced pancreatic {beta}-cell dysfunction and apoptosis through glucokinase nitration and its down-regulation. J Biol Chem. 2010;285(48):37251–62.PubMedCentralPubMed
170.
Chen G, Zhang Y, Lu D, Li NQ, Ross AC. Retinoids synergize with insulin to induce hepatic Gck expression. Biochem J. 2009;419(3):645–53.PubMedCentralPubMed
171.
Jang WY, Bae KB, Kim SH, et al. Overexpression of Jazf1 reduces body weight gain and regulates lipid metabolism in high fat diet. Biochem Biophys Res Commun. 2014;444(3):296–301.PubMed
172.
Collins JF, Hu Z. Promoter analysis of intestinal genes induced during iron-deprivation reveals enrichment of conserved SP1-like binding sites. BMC Genomics. 2007;8:420.PubMedCentralPubMed
173.
Rank G, Sutton R, Marshall V, et al. Novel roles for erythroid Ankyrin-1 revealed through an ENU-induced null mouse mutant. Blood. 2009;113(14):3352–62.PubMedCentralPubMed
174.
Seo HJ, Kim HC, Klein TA, et al. Molecular detection and genotyping of Japanese encephalitis virus in mosquitoes during a 2010 outbreak in the Republic of Korea. PLoS ONE. 2013;8(2):e55165.PubMedCentralPubMed
175.
Wijesekara N, Chimienti F, Wheeler MB. Zinc, a regulator of islet function and glucose homeostasis. Diabetes Obes Metab. 2009;11 Suppl 4:202–14.PubMed
176.
Siavoshian S, Blottiere HM, Cherbut C, Galmiche JP. Butyrate stimulates cyclin D and p21 and inhibits cyclin-dependent kinase 2 expression in HT-29 colonic epithelial cells. Biochem Biophys Res Commun. 1997;232(1):169–72.PubMed
177.
Wang L, Mear JP, Kuan CY, Colbert MC. Retinoic acid induces CDK inhibitors and growth arrest specific (Gas) genes in neural crest cells. Dev Growth Differ. 2005;47(3):119–30.PubMed
178.
179.
Han M, Serrano MC, Lastra-Vicente R, et al. Folate rescues lithium-, homocysteine- and Wnt3A-induced vertebrate cardiac anomalies. Dis Model Mech. 2009;2(9–10):467–78.PubMedCentralPubMed
180.
Perlman RK, Rosner MR. Identification of zinc ligands of the insulin-degrading enzyme. J Biol Chem. 1994;269(52):33140–5.PubMed
181.
Brandimarti P, Costa-Junior JM, Ferreira SM, et al. Cafeteria diet inhibits insulin clearance by reduced insulin-degrading enzyme expression and mRNA splicing. J Endocrinol. 2013;219(2):173–82.PubMed
182.
Du J, Zhang L, Liu S, Wang Z. Palmitic acid and docosahexaenoic acid opposingly regulate the expression of insulin-degrading enzyme in neurons. Die Pharm. 2010;65(3):231–2.
183.
Bellia F, Grasso G. The role of copper(II) and zinc(II) in the degradation of human and murine IAPP by insulin-degrading enzyme. J Mass Spectrom. 2014;49(4):274–9.PubMed
184.
Beildeck ME, Islam M, Shah S, Welsh J, Byers SW. Control of TCF-4 expression by VDR and vitamin D in the mouse mammary gland and colorectal cancer cell lines. PLoS ONE. 2009;4(11):e7872.PubMedCentralPubMed
185.
Winbo A, Sandstrom O, Palmqvist R, Rydberg A. Iron-deficiency anaemia, gastric hyperplasia, and elevated gastrin levels due to potassium channel dysfunction in the Jervell and Lange-Nielsen Syndrome. Cardiol Young. 2013;23(3):325–34.PubMed
186.
Piron J, Choveau FS, Amarouch MY, et al. KCNE1-KCNQ1 osmoregulation by interaction of phosphatidylinositol-4,5-bisphosphate with Mg2+ and polyamines. J Physiol. 2010;588(Pt 18):3471–83.PubMedCentralPubMed
187.
Iriti M, Varoni EM, Vitalini S. Melatonin in traditional Mediterranean diets. J Pineal Res. 2010;49(2):101–5.PubMed
188.
Bediz CS, Baltaci AK, Mogulkoc R. Both zinc deficiency and supplementation affect plasma melatonin levels in rats. Acta Physiol Hung. 2003;90(4):335–9.PubMed
189.
Fournier I, Ploye F, Cottet-Emard JM, Brun J, Claustrat B. Folate deficiency alters melatonin secretion in rats. J Nutr. 2002;132(9):2781–4.PubMed
190.
Reiter RJ, Manchester LC, Tan DX. Melatonin in walnuts: influence on levels of melatonin and total antioxidant capacity of blood. Nutrition. 2005;21(9):920–4.PubMed
191.
Stamateris RE, Sharma RB, Hollern DA, Alonso LC. Adaptive beta-cell proliferation increases early in high-fat feeding in mice, concurrent with metabolic changes, with induction of islet cyclin D2 expression. Am J Physiol Endocrinol Metab. 2013;305(1):E149–59.PubMedCentralPubMed
192.
Jaholkowski P, Mierzejewski P, Zatorski P, et al. Increased ethanol intake and preference in cyclin D2 knockout mice. Genes Brain Behav. 2011;10(5):551–6.PubMed
193.
Zancai P, Cariati R, Rizzo S, Boiocchi M, Dolcetti R. Retinoic acid-mediated growth arrest of EBV-immortalized B lymphocytes is associated with multiple changes in G1 regulatory proteins: p27Kip1 up-regulation is a relevant early event. Oncogene. 1998;17(14):1827–36.PubMed
194.
Li Y, Glozak MA, Smith SM, Rogers MB. The expression and activity of D-type cyclins in F9 embryonal carcinoma cells: modulation of growth by RXR-selective retinoids. Exp Cell Res. 1999;253(2):372–84.PubMed
195.
Ma Y, Feng Q, Sekula D, Diehl JA, Freemantle SJ, Dmitrovsky E. Retinoid targeting of different D-type cyclins through distinct chemopreventive mechanisms. Cancer Res. 2005;65(14):6476–83.PubMed
196.
Giannini G, Di Marcotullio L, Ristori E, et al. HMGI(Y) and HMGI-C genes are expressed in neuroblastoma cell lines and tumors and affect retinoic acid responsiveness. Cancer Res. 1999;59(10):2484–92.PubMed
197.
Song YH, Ray K, Liebhaber SA, Cooke NE. Vitamin D-binding protein gene transcription is regulated by the relative abundance of hepatocyte nuclear factors 1alpha and 1beta. J Biol Chem. 1998;273(43):28408–18.PubMed
198.
Manzardo AM, Gunewardena S, Wang K, Butler MG. Exon microarray analysis of human dorsolateral prefrontal cortex in alcoholism. Alcohol Clin Exp Res. 2014;38(6):1594–601.PubMed
199.
Kwatra D, Subramaniam D, Ramamoorthy P, et al. Methanolic extracts of bitter melon inhibit colon cancer stem cells by affecting energy homeostasis and autophagy. Evid Based Complement Alternat Med. 2013;2013:702869.PubMedCentralPubMed
200.
Shah M, Stebbins JL, Dewing A, Qi J, Pellecchia M, Ronai ZA. Inhibition of Siah2 ubiquitin ligase by vitamin K3 (menadione) attenuates hypoxia and MAPK signaling and blocks melanoma tumorigenesis. Pigment Cell Melanoma Res. 2009;22(6):799–808.PubMedCentralPubMed
201.
Barbachano A, Ordonez-Moran P, Garcia JM, et al. SPROUTY-2 and E-cadherin regulate reciprocally and dictate colon cancer cell tumourigenicity. Oncogene. 2010;29(34):4800–13.PubMed
202.
Park SH, Lee H, Park KK, Kim HW, Park T. Taurine-responsive genes related to signal transduction as identified by cDNA microarray analyses of HepG2 cells. J Med Food. 2006;9(1):33–41.PubMed
203.
Johnstone KA, Diakogiannaki E, Dhayal S, Morgan NG, Harries LW. Dysregulation of Hnf1b gene expression in cultured beta-cells in response to cytotoxic fatty acid. JOP. 2011;12(1):6–10.PubMed
204.
van Angelen AA, San-Cristobal P, Pulskens WP, Hoenderop JG, Bindels RJ. The impact of dietary magnesium restriction on magnesiotropic and calciotropic genes. Nephrol Dial Transplant. 2013;28(12):2983–93.PubMed
205.
Adalat S, Woolf AS, Johnstone KA, et al. HNF1B mutations associate with hypomagnesemia and renal magnesium wasting. J Am Soc Nephrol. 2009;20(5):1123–31.PubMedCentralPubMed
206.
De Miranda J, Panizzutti R, Foltyn VN, Wolosker H. Cofactors of serine racemase that physiologically stimulate the synthesis of the N-methyl-D-aspartate (NMDA) receptor coagonist D-serine. Proc Natl Acad Sci U S A. 2002;99(22):14542–7.PubMedCentralPubMed
207.
Olney JJ, Navarro M, Thiele TE. Targeting central melanocortin receptors: a promising novel approach for treating alcohol abuse disorders. Front Neurosci. 2014;8:128.PubMedCentralPubMed
208.
Shelkar GP, Kale AD, Singh U, Singru PS, Subhedar NK, Kokare DM. Alpha-melanocyte stimulating hormone modulates ethanol self-administration in posterior ventral tegmental area through melanocortin-4 receptors. Addict Biol. 2014.
209.
Navarro M, Lerma-Cabrera JM, Carvajal F, Lowery EG, Cubero I, Thiele TE. Assessment of voluntary ethanol consumption and the effects of a melanocortin (MC) receptor agonist on ethanol intake in mutant C57BL/6J mice lacking the MC-4 receptor. Alcohol Clin Exp Res. 2011;35(6):1058–66.PubMedCentralPubMed
210.
Panaro BL, Cone RD. Melanocortin-4 receptor mutations paradoxically reduce preference for palatable foods. Proc Natl Acad Sci U S A. 2013;110(17):7050–5.PubMedCentralPubMed
211.
Schwinkendorf DR, Tsatsos NG, Gosnell BA, Mashek DG. Effects of central administration of distinct fatty acids on hypothalamic neuropeptide expression and energy metabolism. Int J Obes (Lond). 2011;35(3):336–44.
212.
Naitoh R, Miyawaki K, Harada N, et al. Inhibition of GIP signaling modulates adiponectin levels under high-fat diet in mice. Biochem Biophys Res Commun. 2008;376(1):21–5.PubMed
213.
Li Q, Zhong W, Qiu Y, et al. Preservation of hepatocyte nuclear factor-4alpha contributes to the beneficial effect of dietary medium chain triglyceride on alcohol-induced hepatic lipid dyshomeostasis in rats. Alcohol Clin Exp Res. 2013;37(4):587–98.PubMedCentralPubMed
214.
Kang X, Zhong W, Liu J, et al. Zinc supplementation reverses alcohol-induced steatosis in mice through reactivating hepatocyte nuclear factor-4alpha and peroxisome proliferator-activated receptor-alpha. Hepatology. 2009;50(4):1241–50.PubMedCentralPubMed
215.
Yamaguchi N, Miyamoto S, Ogura Y, Goda T, Suruga K. Hepatocyte nuclear factor-4alpha regulates human cellular retinol-binding protein type II gene expression in intestinal cells. Am J Physiol Gastrointest Liver Physiol. 2009;296(3):G524–33.PubMed
216.
Rajas F, Gautier A, Bady I, Montano S, Mithieux G. Polyunsaturated fatty acyl coenzyme A suppress the glucose-6-phosphatase promoter activity by modulating the DNA binding of hepatocyte nuclear factor 4 alpha. J Biol Chem. 2002;277(18):15736–44.PubMed
Metadata
Title
Gene-Diet Interactions in Type 2 Diabetes
Author
Marilyn C. Cornelis
Publication date
01-12-2014
Publisher
Springer US
Published in
Current Nutrition Reports / Issue 4/2014
Electronic ISSN: 2161-3311
DOI
https://doi.org/10.1007/s13668-014-0095-1

Other articles of this Issue 4/2014

Current Nutrition Reports 4/2014 Go to the issue

Diabetes and Obesity (MR Carnethon, Section Editor)

Dietary Management of Diabetic Chronic Kidney Disease

Public Health and Translational Medicine (PW Franks, Section Editor)

Antenatal Dietary and Lifestyle Interventions for Women Who are Overweight or Obese: Outcomes from the LIMIT Randomized Trial

Public Health and Translational Medicine (PW Franks, Section Editor)

The Look AHEAD Trial: A Review and Discussion of Its Outcomes

Public Health and Translational Medicine (PW Franks, Section Editor)

Prevention of Diabetes Through Lifestyle Intervention: Lessons Learned from the Diabetes Prevention Program and Outcomes Study and its Translation to Practice

Public Health and Translational Medicine (PW Franks, Section Editor)

The EPIC-InterAct Study: A Study of the Interplay between Genetic and Lifestyle Behavioral Factors on the Risk of Type 2 Diabetes in European Populations

Diabetes and Obesity (MR Carnethon, Section Editor)

The Intersection between Food Insecurity and Diabetes: A Review

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24 to hear Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits